- Cancer Immunology and experimental oncology
- Tumor genetic instability and immunogenicity
- Biomarkers and Functional genomics
The scientific program will be designed to foster interactions between scientists from academia and Industry and will involve a multidisciplinary approach by basic scientists, clinicians and epidemiologists. In order to contribute to mechanisms which would transform research breakthroughs into innovative products, the research teams will be working in partnership with international institutions to collaborate and achieve excellence towards producing quality research.